Evidence map›Paper›PMID 37673957›Full record

ArticleHypertension research : official journal of the Japanese Society of Hypertension2024

Prevalence of true resistant hypertension in those referred for uncontrolled hypertension in Malaysia: A comparison using different definitions.

John Jui Ping Yeo, Leh Siang Yeo, Shirley Siang Ning Tan, Dayang Diana Rozana Aini Delailah, Shaun Wen Huey Lee, Anna Ting Huey Hu, Diana Hui Ping Foo, Faiz Sahiran, Ivan Kok Seng Yap, Alan Yean Yip Fong

Abstract read
PubMed Publisher
In one paragraph

Article in Hypertension research : official journal of the Japanese Society of Hypertension, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Observational
  2. Resistant hypertension: diagnosis, evaluation, and treatment a clinical consensus statement from the Thai hypertension society.Hypertension research : official journal of the Japanese Society of Hypertension · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

John Jui Ping YeoClinical Research Center, Institute for Clinical Research, Sarawak General Hospital, Kuching, Malaysia.
Leh Siang YeoClinical Research Center, Institute for Clinical Research, Sarawak General Hospital, Kuching, Malaysia.
Shirley Siang Ning TanClinical Research Center, Institute for Clinical Research, Sarawak General Hospital, Kuching, Malaysia.
Dayang Diana Rozana Aini DelailahClinical Research Center, Institute for Clinical Research, Sarawak General Hospital, Kuching, Malaysia.
Shaun Wen Huey LeeMonash University Malaysia, Selangor, Malaysia.
Anna Ting Huey HuClinical Research Center, Institute for Clinical Research, Sarawak General Hospital, Kuching, Malaysia.
Diana Hui Ping FooClinical Research Center, Institute for Clinical Research, Sarawak General Hospital, Kuching, Malaysia.
Faiz SahiranKlinik Kesihatan Petra Jaya, Ministry of Health Malaysia, Sarawak, Malaysia.
Ivan Kok Seng YapSarawak Research and Development Council, Kuching, Malaysia.
Alan Yean Yip FongClinical Research Center, Institute for Clinical Research, Sarawak General Hospital, Kuching, Malaysia. alanfong@crc.gov.my.
Sarawak General Hospital · MYForest Department Sarawak · MYMinistry of Health · MYMonash University Malaysia · MYSarawak Biodiversity Centre · MY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Resistant hypertension is a well-recognised clinical challenge. However, the definition and epidemiology of true resistant hypertension (RH) are less understood, especially in Asia. This cross-sectional study examined the prevalence of RH referred from primary care clinics based on various guidelines. RH was defined as blood pressure (BP) being above the threshold using ambulatory blood pressure monitoring despite adequate lifestyle measures and optimal treatment with ≥3 medications at maximally tolerated doses. Between one in four (n = 94, 24.0% using Malaysian guidelines) and up to two-thirds (n = 249, 63.7% using 2018 American guidelines) of adults referred for uncontrolled hypertension met the criteria of true RH. Of those with RH, a further one-quarter (n = 26, 26.6%) were deemed to have refractory hypertension (elevated BP despite treatment with at least 5 antihypertensive medications). Adults with RH were generally younger, more likely to be male, had a higher BMI and were more likely to have gout, CKD, and angina compared to those with controlled hypertension. The prevalence of RH amongst Asian adults with poor hypertension control is high. A concerted effort is needed to reduce the high burden of RH, especially among this population.

Indexed as

Blood Pressure Monitoring, AmbulatoryHypertensionAdultAntihypertensive AgentsBlood PressureCross-Sectional StudiesFemaleHumansMalaysiaMalePrevalenceRisk FactorsUnited StatesAntihypertensive AgentsMalaysiaPrevalenceRefractory hypertensionResistant hypertension

Identifiers

PMID37673957
OpenAlexW4386482317

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.